Clinical Trial: Diagnostic Accuracy of 18F-FDG PET/CT in Muscle-invasive Bladder Cancer

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07750470) titled 'Diagnostic Accuracy of 18F-FDG PET/CT in Muscle-invasive Bladder Cancer' on Feb. 23.

Brief Summary: MIBC-PET is a prospective, monocentric, no-profit study with paired imaging comparison enrolling 60 patients with newly diagnosed, histologically confirmed high-grade MIBC. All patients undergo baseline staging with [18F]FDG PET/CT and contrast-enhanced CT (ceCT) of chest, abdomen, and pelvis. A second [18F]FDG PET/CT and CT are performed after two cycles of neoadjuvant therapy. [18F]FDG PET/CT includes both standard delayed imaging and an early dynamic pelvic acquisition to overcome urinary tracer interference. The primary endpoints a...